Beam Therapeutics sues Chinese biotech startup over alleged IP theft by former scientist

Beam Therapeutics filed a lawsuit alleging a former scientist stole gene-editing intellectual property and used it to co-found a Chinese biotech that secured VC funding. The claim is unverified and the case is at an early stage. This matters as it highlights cross-border IP enforcement risks in the biotech sector.